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Abstract (226 words) 
Background. Cardiopulmonary exercise testing (CPET) measures peak exertional oxygen 
consumption (V̇O2 peak) and V̇O2 at anaerobic threshold (V̇O2 at AT- the point at which anaerobic 
metabolism contributes substantially to overall metabolism). Lower values are associated with 
excess postoperative morbidity and mortality. A reduced haemoglobin concentration may result 
from a fall in total haemoglobin mass (tHb-mass), or rise in plasma volume.  Thus, tHb-mass may 
be a more useful measure of oxygen carrying capacity, and may correlate better with CPET-
derived fitness measures in preoperative patients, than does circulating haemoglobin concentration 
([Hb]). We tested this hypothesis.   
Methods. Prior to major elective surgery, CPET was performed, and both tHb-mass (optimised 
carbon-monoxide rebreathing method, oCOR and circulating [Hb] determined.  
Results. In 42 patients (83% male), [Hb] was unrelated to V̇O2 at AT and V̇O2 peak (r= 0.02, p= 
0.89;  r= 0.04, p= 0.80 respectively) and explained none of the variance in either measure. In 
contrast,  tHb-mass was related to both (r= 0.661, p< 0.0001; r= 0.483, p= 0.001) for V̇O2 at AT 
and V̇O2 peak respectively and tHb-mass explained 43.7% of variance in V̇O2 at AT (p< 0.0001) 
and 23.3% in V̇O2 peak  (p= 0.001).   
Conclusions. In contrast to [Hb], tHb-mass is an important determinant of physical fitness prior to 
major elective surgery. Further studies should determine whether this is reflected in poor outcome, 
and whether targeted increases in tHb-mass might thus improve outcome. 
 
MESH key words  
Physical fitness; Cardiopulmonary Exercise Test; Oxygen Consumption; Anaerobic Threshold; 
Surgery; Anaemia 
 
  
 3 
Cardiopulmonary exercise testing (CPET) is routinely used to quantify exertional oxygen 
consumption (V̇O2)- both the peak attained (V̇O2 peak) and that at the anaerobic threshold (V̇O2  at 
AT: the point during incremental exercise when anaerobic metabolism makes a significant 
contribution to overall metabolism).  Both measures are used as indices of physical fitness prior to 
major surgery,1-3 given that reduced values are associated with increased postoperative morbidity 
and mortality.4 5   
 
Haemoglobin (Hb), in circulating red blood cells (RBCs), is the blood’s oxygen carrying pigment. 
Its circulating concentration ([Hb]) reflects both its total circulating mass (tHb-mass) and the 
volume of plasma in which the RBCs are suspended.  Anaemia, defined as [Hb] <130 g l-1 in men 
and <120 g l-1  in women,6 is associated with decreased aerobic exercise capacity.7-9 Preoperative 
anaemia is common (affecting one third of surgical patients) and is associated with an increased 
risk postoperative morbidity and mortality.10-11  
 
Because the proportion of oxygen (O2) carried in plasma is trivial, the relationship of aerobic 
fitness with tHb-mass might be stronger than that with [Hb]. Indeed, in healthy individuals, [Hb] 
does not significantly correlate with either V̇O2 peak or V̇O2max,12 13 unlike tHb-mass.14-15 
However, whether this applies to patient populations- and to perioperative patients in particular- is 
less certain. We thus sought to explore the relationship of [Hb] and tHb-mass with CPET-derived 
measures of physical fitness in preoperative patients.  
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Methods  
Ethical approval was granted by the London, Camden and Kings Cross Research Ethics 
Committee (REC reference: 13/LO/1901).  We fully adhered to Caldicott guidelines and followed 
the standards established by the Declaration of Helsinki. All participants provided written 
informed consent prior to taking part. 
Patients 
Adult (> 18 years) elective (non-cardiac) surgical patients at University College Hospital 
(University College London Hospitals NHS Foundation Trust) and Southampton General Hospital 
(University Hospital Southampton NHS Foundation Trust) were prospectively studied between 
February and August 2015.  Patients were either receiving CPET as part of their routine 
preoperative assessment, or were (approved) co-recruits to the ‘METS’ study of the relationship 
between CPET derived physiological variables and surgical outcome.16 Age, gender, height, 
weight, diagnosis, planned surgical procedure, comorbidities (such as diagnosis of diabetes, 
respiratory or cardiovascular disease) and current medications were documented.  
Cardiopulmonary Exercise Testing 
CPET was supervised by a clinical exercise physiologist (and clinician where appropriate) and 
performed in accordance with international guidelines.17 
Patients cycled on an electromagnetically-braked ergometer (UCLH- Lode BV, Groningen, 
Netherlands; Southampton- Ergoline 2000, Ergoline GmbH, Bitz, Germany) with respiratory gas 
analysis made by calibrated metabolic carts [UCLH-Cortex Biophysik, Leipzig, Germany; 
Southampton- Geratherm Respiratory GmbH (Love Medical Ltd, Manchester, UK)]. Breath-by-
breath oxygen uptake (V̇O2) and carbon dioxide (CO2) output (V̇CO2) were recorded, concurrently 
with minute ventilation, tidal volume, respiratory rate, and end-tidal gas tensions for O2 and CO2. 
Patients were connected to appropriate monitoring equipment and rested for an initial 3-minute 
period, after which 3-minutes of unloaded cycling was completed.  Subsequently, patients 
performed a symptom-limited incremental ramp test set to 10-20 W min-1 (based on patient height, 
weight and age) such as to deliver an intended test duration of  8 to 12 minutes.18 Test cessation 
occurred at patient exhaustion, or when cadence fell below 40 rpm for more than 30 seconds in 
spite of verbal encouragement. CPET was terminated by testing staff on safety grounds if the 
patient developed a sign or symptom listed in the ATS/ACCP CPET guidelines.17  After stopping 
CPET, patients completed a 3-5 minute period of unloaded cycling to ‘cool down’. 
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The anaerobic threshold (ml kg-1 min-1) was determined by a clinical exercise physiologist and/or 
consultant physician, both skilled in CPET analysis, using the modified V-slope method with 
corroboration by ventilatory equivalents and end-tidal gas tensions for O2 and CO2.
19  The highest 
average V̇O2 over the final 30s of exercise was recorded as the V̇O2 peak (ml kg-1 min-1).20 
Optimised Carbon Monoxide Rebreathing Method (oCOR) 
tHb-mass was determined using the optimised carbon monoxide (CO) rebreathing method 
described in detail by Schmidt and Prommer 21 and was calculated based on the equation in Figure 
1.  In brief, CO binds avidly to Hb. Carboxyhaemoglobin (COHb) concentration is measured in 
blood before and after 2 minutes of rebreathing a known CO volume.  In this study the CO 
volume used ranged between 0.5 to 0.9 ml kg-1, depending on gender in the first instance, with 
fine tuning by [Hb], body mass index and the general condition of the patient.  Each participant 
was seated for 15 minutes to allow stabilisation of plasma volume, after which a mouthpiece 
containing ~10g ‘soda lime’ (calcium oxide/sodium hydroxide mixture as a carbon dioxide 
scrubber) connected them to a spirometer (Spico-CO Respirations-Applikator, Blood Tec, 
Germany) and a 3 litre anaesthetic bag pre-filled with 100% oxygen.  The patient completely 
exhaled to residual volume and was then instructed to take a deep breath in through the spirometer 
as the CO dose was administered via a pre-filled 100 ml syringe.  To support the diffusion of CO 
into the blood the patient held their breath for 10 s after the first inspiration, thereafter normal 
breathing from the spirometer was performed for a further 1 min 50 s.  The participant was 
disconnected after exhaling to residual volume, the exhaled volume being collected and analysed 
to quantify the CO not absorbed into the bloodstream.  Finally, participants fully exhaled to 
residual volume into a CO gas analyser (Dräger Pac 7000, Drägerwerk AG & Co. KGaA, 
Germany) before and at minute 4 after CO rebreathing to determine the CO volume exhaled after 
disconnecting the patient from the spirometer.  
 
Blood sampling 
Fingertip capillary samples (200 μl) were collected before and 6- and 8-min after the start of CO 
rebreathing (Na-heparinized 200 μl RAPIDLyte Multicap Capillary tubes, Siemens Healthcare 
Diagnostics Inc, Deerfield, USA), with samples analysed within 15 minutes for percent 
carboxyhaemoglobin (%COHb) using a blood gas analyser (Hemoximeter; Cobas b 221 POC 
system, Roche Diagnostics Ltd, Switzerland). At Southampton, [Hb] was measured in venous 
blood. An intravenous cannula was inserted prior to tHb-mass testing at Southampton, allowing 
venous blood samples (200 μl) to be collected before and at 6- and 8-mins after CO rebreathing 
via a Na-heparinized blood gas syringe (RAPIDLyte, Siemens Healthcare Diagnostics Inc, 
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Deerfield, USA). Percent carboxyhaemoglobin was determined at Southampton using the 
RAPIDPoint 500 Blood Gas System (Siemens Healthcare Diagnostics Inc, Deerfield, USA).  
Blood sampling from venous, arterial and capillary blood yields an identical ∆%COHb and 
therefore identical tHb-mass values. 22 All blood samples for the determination of [Hb], Hct and 
%COHb were collected under the same conditions, from the same site, with patients in a seated 
position.  Blood samples were analysed within 10-15 minutes of one another due to %COHb 
being analysed after the oCOR test using a blood gas machine (which takes 15 minutes). 
 
Calculations 
tHb-mass was calculated using a specifically designed excel spreadsheet (Microsoft Excel 2016 
for Apple Macintosh) based on the equation in Figure 1.  Also shown in Figure 1 are calculations 
for blood volume (BV), erythrocyte volume (EV) and plasma volume (PV).  When Hct and [Hb] 
values were acquired from capillary blood at UCLH these values were corrected to venous 
conditions using the following formulas: 23 24 
[Hb] (g dl-1) = [Hbcapillary] • 0.8787 + 1.24 
Hct (%) = [Hctcapillary] • 0.8425 + 5.23 
 
Statistical analysis 
Statistical analysis was carried out using SPSS Statistics (Version 23.0 for Apple Mackintosh, 
Chicago, IL).  Values are presented as mean (standard deviation, SD), unless otherwise stated.  
Median and interquartile range (IQR) are reported when variables are not normally distributed and 
when data transformation (logarithmic, square root or reciprocal) did not result in a normally 
distributed variable.  Categorical variables are presented as frequency (%).  Normal (Gaussian) 
distribution was assessed using a combination of the Kolmogorov-Smirnov test, visual inspection 
of histogram charts and normal Q-Q plots for each variable.  Pearson’s correlation coefficient 
assessed the relationship between [Hb], tHb-mass and exertional V̇O2 allowing adjustment for 
confounding.  Linear regression models assessed the associations between V̇O2 and 
haematological variables ([Hb] and tHb-mass) and the proportion of variance in V̇O2 explained by 
[Hb] and tHb-mass, allowing adjustment for confounding. Specifically, age, gender, smoking 
status, diabetes and the presence of cardiovascular disease (defined if a patient had either 
ischaemic heart disease, heart failure of previous stroke) were included as confounders in both 
correlation and regression analyses. [Hb], tHb-mass, exertional V̇O2 at AT and V̇O2 peak were 
expressed in g l-1, g kg-1 and ml kg-1 min-1, respectively for both correlation and regression 
analyses.  Elsewhere, V̇O2 is expressed in ml kg-1 min-1 and tHb-mass in g kg-1 unless otherwise 
stated.  All tests were two-sided with statistical significance was accepted as a p-value of < 0.05.   
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Results 
Forty-three patients (24 from University College London Hospital and 19 from Southampton 
General Hospital) consented to take part in the study. One failed to successfully complete the 
oCOR protocol and so was excluded.  Patient characteristics, including surgical specialty, are 
shown in Table 1.  No major adverse clinical events occurred during CPET. The mean (SD) V̇O2 
peak and AT were 15.7 (5.9) and 10.2 (2.3) ml kg-1 min-1.  AT could not be determined in 3 
patients, although their V̇O2 peak data were used in analyses where appropriate. Mean (SD) [Hb] 
and tHb-mass were 135.6 (15.6) g l-1 and 8.2 (1.3) g kg-1.  Table 2 shows other haematological 
variables.    
 
Relationships between haematological variables and oxygen uptake 
[Hb] was unrelated to either V̇O2 at AT (r= 0.02, p= 0.89) or V̇O2 peak (r= 0.041, p= 0.796).  
However, tHb-mass was associated with V̇O2 at AT and V̇O2 peak (r= 0.661 and 0.483, p= 0.001 
and < 0.0001 respectively:  Figure 2).  After adjusting for age, gender, diabetes, smoking status, 
and the presence of cardiovascular disease, tHb-mass remained correlated with V̇O2 at AT (r= 
0.629, p< 0.0001) and V̇O2 peak (r= 0.412, p= 0.011).   
 
Linear Regression Models 
[Hb] did not explain any of the variance in V̇O2 at AT (adjusted R2= -0.027, p= 0.892) or V̇O2 
peak (adjusted R2= -0.023, p= 0.796).  In contrast, tHb-mass explained 43.7% of the variance in 
V̇O2 at AT (p< 0.0001) and 23.3% in V̇O2 peak (p= 0.001).  A 1 g kg-1 increase in tHb-mass was 
associated with a 1.0 ml kg-1 min-1 increase in AT (p< 0.0001), after adjusting for age, gender, 
smoking status, diabetes, and the presence of cardiovascular disease.  Similarly, a 1 g kg-1 increase 
in tHb-mass was associated with a 2.0 ml kg-1 min-1 increase in V̇O2 peak (p= 0.01) after 
adjustment for age, sex, smoking status, diabetes, and the presence of cardiovascular disease. A 
summary of the linear regression analyses can be found in Tables 1 and 2 of the supplementary 
material.  
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Discussion 
To our knowledge, this is the only study to have explored the relationship between total 
haemoglobin mass and physical fitness determined by cardiopulmonary exercise testing in 
patients awaiting major surgery. Whilst [Hb] was unrelated to exertional V̇O2 at either AT or V̇O2 
peak (ml kg-1 min-1), total haemoglobin mass (g kg-1) was associated with V̇O2 at AT (r= 0.66) and 
V̇O2 peak (r= 0.48), even after adjusting for measured confounding variables.  Some 44% of the 
variance in V̇O2 at AT was attributable to tHb-mass, which may be of particular importance in the 
peri-operative setting, given the consistent link between V̇O2 at AT and surgical outcome. 
 
There are few published clinical data with which to compare our results.  However, in 12 men 
with type 1 diabetes (T1DM) and 23 controls, Koponen and colleagues found that [Hb] was not 
associated with V̇O2 peak, while body mass normalised tHb-mass was strongly related to V̇O2 
peak (r= 0.71, p< 0.01, explaining 51% of the variance in V̇O2 peak) in T1DM patients.25 This 
study did not, however, report the relationship between tHb-mass and AT.  The strength of this 
correlation between tHb-mass and V̇O2 peak (r= 0.71) was stronger than that which we identified   
(r= 0.48).  This may in part be explained by differences in relatively small sample sizes, 
differences (albeit small) in measurement error inherent in both oCOR test and CPET 
measurement, and (perhaps to a greater extent) by V̇O2 peak being dependent upon 
patient/participant volition and motivation.  If this is the case then the relationships between V̇O2 
peak and tHb-mass may be underestimated in the current study.  In general, the finding that tHb-
mass displays a stronger relationship with V̇O2 peak than does [Hb], is consistent with previous 
reports in healthy volunteers and trained athletes (r= 0.79 in pooled data from 611 subjects;15 r = 
0.48, 0.79 and 0.92 in male runners, and male and female rowers, respectively).26    
 
Mean AT measurements of 10 ml kg-1 min-1 and V̇O2 peak measurements of 16 ml kg-1 min-1 are in 
keeping with preoperative data reported by others.3 27 So, too, is the high prevalence of  anaemia 
(26%).10 11 Our mean (SD) tHb-mass 677 (146) g, or 8.2 (1.3) g kg-1 was lower than that report by 
Koponen and colleagues 25 for T1DM (722 (121) g and 10.1 (1.5) g kg-1) and healthy controls 
(898 (96) g and 11.0 (1.1) g kg-1 respectively).  Furthermore, our values are substantially lower 
than those reported in endurance athletes, mean (SD) tHb-mass 1285 (123) g and 13.7 (0.5) g kg-1 
in elite rowers, 28 tHb-mass 958 (123) g in trained cyclists, 24 and in excess of 14.5 g kg-1 in elite 
marathon runners.12  Such high tHb-mass values only appear to  be legally reached by years of 
intensive training or the influence of strong genetic factors 13 but may also be influenced by elicit 
use of erythryopoeitin and/or blood transfusion, previously common practice in many endurance 
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sports.  Data from untrained subjects suggest that improvements in V̇O2 peak following only 6 
weeks of endurance training are largely due to increases in peak cardiac output and O2 carrying 
capacity (quantified by red cell volume and tHb-mass).29 Given that prolonged endurance training 
is largely not feasible in patients awaiting major surgery,  alternative interventions to increase 
tHb-mass preoperatively (and thus aerobic fitness and related surgical outcome) are worthy of 
exploration. In addition, preoperative anaemia is associated with an increased risk of 
postoperative morbidity and mortality,10-11 and it would thus perhaps be surprising if a similar 
relationship was lacking for tHb-mass.  Furthermore, as we have shown a close relationship 
between tHb-mass and preoperative fitness, and given the link between exertional V̇O2 and 
surgical outcome, it would seem logical to purport that a high tHb-mass may be advantageous to 
patient outcomes in the perioperative setting, although this remains to be confirmed.  
 
Once tHb-mass has been quantified, other blood volume compartments can be derived providing 
[Hb] and Hct (%) are measured.  Specific formulae shown in Figure 1 allow the calculation of 
BV, EV and PV.  In the context of anaemia, these variables offer additional insight into the 
haematological and volume status of patients given that the measured [Hb] can be affected by 
both changes in tHb-mass and PV, independently of one another.  As shown in Table 2, tHb-mass 
(g & g kg-1) and EV (ml & ml kg-1) did not significantly differ between anaemic and non-anaemic 
patients.  However, BV (ml kg-1) and PV (ml & ml kg-1) were expanded in anaemic patients, 
suggesting to some extent that anaemia in this small sample may in part be related to PV 
expansion rather than a deficit in oxygen carrying capacity as quantified by tHb-mass.  Thus, 
dilutional anaemia may not have such negative effects on exercise capacity as ‘true’ anaemia, 
being characterised by a deficit in tHb-mass.  This may to some extent explain the lack of 
association between [Hb] and exertional V̇O2.  In future studies the aetiology of anaemia should 
therefore also be evaluated.  Indeed, in the current study median creatinine concentrations were 
numerically (but not statistically significantly) higher in anaemic patients, suggesting chronic 
kidney disease as a potential underlying cause of anaemia.  However, it was not the aim of this 
study to elucidate the underlying aetiology of anaemia, and larger studies (with greater power) 
would be needed to determine if renal impairment contributed significantly to the prevalence of 
preoperative anaemia. 
 
Strengths and weaknesses 
Strengths of this study include the prospective nature of the use of CPET (considered the gold 
standard) to determine preoperative exercise capacity, and the use of the oCOR as a reliable and 
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precise measure of tHb-mass.30 Indeed, oCOR is a simple, convenient and cheap methodology 
which doesn’t involve the use of radioisotopes (as 51Chromium-labelling of red cells does).  This 
greatly widens its applicability in the clinical setting.  Finally, the lack of observed association 
between [Hb] and exertional V̇O2 is a strength and is in keeping with a number of studies in 
healthy volunteers and endurance trained athletes.13 30   
 
Potential weaknesses of the current study include the relatively small sample size, although this 
study was adequately powered to explore the relationship between tHb-mass and exertional V̇O2 
(achieved power of 0.91, based on sample size of 42, alpha value of 0.05 and correlation of r=0.48 
between weight adjusted tHb-mass and AT).  In addition, to our knowledge, the current study 
cohort is the largest in which the relationship between preoperative tHb-mass and CPET-derived 
physical fitness has been explored and is a larger sample size than the study by Koponen and 
colleagues.25  The use of capillary and venous blood across testing sites (UCLH and 
Southampton) to quantify [Hb] is a weakness, although blood sampling from venous, arterial and 
capillary blood yields an identical ∆%COHb and therefore identical tHb-mass values. 22 Capillary 
[Hb] is generally higher than that measured in venous blood.32-34 Such differences may be related 
to differences in body posture at the time of sampling, as well as factors affecting fingertip 
capillary samples such as skin thickness and temperature.35 In addition, differences in laboratory 
measures of [Hb] in venous blood may have introduced error.  All or some of these potential 
sources of error may have affected the measured [Hb] value and thus impacted upon the 
relationship between [Hb] and exertional V̇O2. However, to minimise such confounding factors, 
[Hb] values obtained from capillary blood were adjusted to venous conditions using established 
formulas and hospital laboratories subject to rigorous quality control. 
 
In addition, use of different blood gas machines may have introduced error in the measurement of 
tHb-mass and different metabolic carts across sites may have impacted upon measured V̇O2.  
However, at UCLH we have previously reported a typical error (TE) of repeat tHb-mass 
measurements of 1.9 % (95% CI 1.3-3.4%) which is in keeping with the TE commonly reported 
by other institutions using the oCOR method.21 37  In addition, both metabolic carts were 
calibrated prior to every CPET. 
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Conclusion and further research 
In a cohort of patients awaiting major elective surgery, total haemoglobin mass (unlike 
haemoglobin concentration) was associated with preoperative cardiorespiratory fitness. Future 
studies may wish to address whether increasing tHb-mass preoperatively leads to improved 
preoperative cardiorespiratory fitness, and thus outcome.  
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Tables  
 
Table 1. Patient characteristics.  Values are expressed as mean (SD), 
median (range) or frequency (%). 
Variable n= 42 
Gender  
  Male 35 (83%) 
  Female 7 (17%) 
Age (yr) 66 (24-78) 
Height (cm) 172 (9) 
Weight (kg) 83 (16) 
Surgical specialty  
  Urology 19 
  Hepatology 9 
  Maxillofacial 2 
  Upper gastrointestinal 3 
  Thoracic 4 
  Vascular 1 
  Gastrointestinal 4 
Morbidities 
  Ischaemic heart disease 
 
5 (12%) 
  Heart failure 1 (2%) 
  Hypertension 19 (45%) 
  Stroke  1 (2%) 
  Diabetes 9 (21%) 
  COPD 6 (14%) 
Smoking history  
  Current 6 (14%) 
  Former 12 (27%) 
  Never 24 (57%) 
Medication  
  Beta blocker 6 (14%) 
  Nitrates 1 (2%) 
  ACE inhibitor 14 (33%) 
  Statin 13 (31%) 
COPD, chronic obstructive pulmonary disease.  
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Table 2. Haematological characteristics for all patients and by presence or absence of anaemia.  
Values are expressed as mean (SD), median (IQR) or frequency (%).   
Variable All patients 
(n= 42) 
Anaemic 
(n= 11) 
Non-anaemic 
(n= 31) 
p-value 
[Hb] (g l-1) 135.6 (15.6) 116.3 (11.7) 142.5 (10.1) < 0.0001 
Hct (%) 41.4 (4.0) 37.4 (4.2) 42.7 (3.0) < 0.0001 
tHb-mass (g) 677 (146) 610 (119) 700 (149) 0.079 
tHb-mass (g kg-1) 8.2 (1.3) 7.8 (1.7) 8.3 (1.2) 0.316 
BV (ml) 5495 (1065) 5753 (951) 5404 (1102) 0.356 
BV (ml kg-1) 67.3 (12.2) 74.7 (16.0) 64.6 (9.6) 0.016 
PV (ml) 3421 (678) 3775 (560) 3295 (680) 0.043 
PV (ml kg-1) 42.0 (8.2) 49.0 (9.4) 39.5 (6.3) 0.001 
PV (%) 62.3 (3.7) 65.9 (3.8) 61.0 (2.7) < 0.0001 
EV (ml) 2074 (462) 1978 (466) 2108 (464) 0.431 
EV (ml kg-1) 25.3 (4.9) 25.6 (7.4) 25.1 (3.9) 0.768 
MCV (fL) 90.5 (4.6) 90.6 (4.3) 89.4 (5.0) 0.521 
MCH (pg) 30.3 (1.9) 29.7 (1.4) 30.4 (2.1) 0.370 
MCHC (g l-1) 342 (321-349) 320 (314-347) 344 (331-350) 0.096 
Creatinine (µmol l-1) 97.5 (50.5) 127.0 (62.7) 88.8 (43.9) 0.055 
Albumin (g l-1) 42 (39-44) 36.0 (7.8) 42.1 (5.0) 0.070 
[Hb], Haemoglobin concentration; Hct, haematocrit; tHb-mass, total haemoglobin mass; BV, 
blood volume; PV, plasma volume; EV, erythrocyte volume; MCV, mean corpuscular volume; 
MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration. 
Anaemia defined according to World Health Organisation criteria when ([Hb])  <130 g l-1 in men 
and <120 g l-1 in women.     
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Figure 2.  Unadjusted relationship between haematological variables and exertional 
oxygen consumption.  Relation of V̇O2 peak (ml kg-1 min-1) to tHb-mass (g kg-1) (A) and 
[Hb] (g l-1) (C) in 42 patients. Relation of AT to tHb-mass (g kg-1) (B) and [Hb] (g l-1) 
(D) in 39 patients. tHb-mass, total haemoglobin mass; [Hb], haemoglobin 
concentration; AT, anaerobic threshold;  V̇O2 peak, peak oxygen.  
 
 
 
tHb-mass (g) = K x MCO(ml) x 100 x (Δ%COHb x 1.39)-1 
 
K = current barometric pressure x 760-1 x [1(0.003661 x current temperature)] 
MCO = COadm – (COsystem + lung (after disconnection) + COexhaled (after disconnection) 
COadm = CO volume administered into the system 
COsystem + lung (after disconnection) = CO concentration in spirometer x (spirometer volume + 
remaining volume in the lung after rebreathing) 
COexhaled (after disconnection) = end-tidal CO concentration x alveolar ventilation x time 
Δ%COHb = difference between baseline %COHb and %COHb post CO administration 
(average of 6- and 8-min %COHb values) 
1.39 = Hüfners number (constant) (ml CO x g Hb-1) 
 
 
BV (ml) = tHb-mass (g)/[Hb] (g dl-1) • 100 
 
EV (ml) = BV (ml) • Hct (%) 
 
PV (ml) = BV – EV 
 
 
Figure 1. Equations to calculate total haemoglobin mass, blood, erythrocyte and plasma 
volumes. CO, carbon monoxide; %COHb, percent carboxyhaemoglobin; [Hb], 
haemoglobin concentration; Hct, haematocrit; BV, blood volume; EV, erythrocyte 
volume; PV, plasma volume; lung residual volume, 1500 ml in men, 1200 ml in 
women; alveolar ventilation, 5000 ml min-1. 
